Scenario of Over the Counter Medicines Worldwide
Over the counter (OTC) drugs are medicines sold directly to consumer without any prescription. The OTC drug market in India is expected to grow by $6.6 billion by 2016 with Pharmaceutical companies and chemists increasing their presence in rural market. The market share of hospitals is expected to increase from 1.3% in 2009 to 26% in 2020. Also the Health Ministry has banned 344 fixed drugs combinations through a gazette notification issued over the weekend March, 2016. These include several cough syrup solutions, analgesics and antibiotic combinations and in which many of are sold over the counter. There is list of banned drugs which include Nimesulide which had been a cause for long for health experts for includes for its continued use in India despite being banned in most of the developed nations. Some of banned drug combinations are: a) Nimesulide + Diclofenac B) Diclofenac + Tramadol + Paracetamol C) Heparin + Diclofenac D) Azithromycin + Cefixime E) Telmisartan + Metformin and many more. Also India’s OTC drug market stood at $3 billion in 2011 and a rise to $6.6 billion is forecast by 2016 according to sectoral document for pharmaceuticals industry. And in future India is known and expected to rank amongst top three pharmaceutical markets in terms of incremental growth by 2020.
https://en.wikipedia.org/wiki/Over-the-counter_drug accessed on 20 Dec, 2016.
2. Rasha Al-Dabbagh and Samah Al-Amassie. Over the counter drugs. [Internet]. slideshare; 2012 Feb 06 [cited 2019 Feb 03]. Available from:
http://www.slideshare.net/RashaDabbagh/otc-drugs?qid= 7a474011-5a4e-4b2e-8bb5-b0db1d602449&v=&b= &from_search=2
3. Ben Giovan Cacho. Top OTC drug. [Internet]. slideshare; 2015 Feb 24 [cited 2019 Feb 04]. Available from:
4. Organisation of pharmaceutical producers in India; by pricewaterhouseCoopers (CIA world factbook, indiastat. com, international monetory fund, WHO, Business monitor international, [Internet]. Indiaoppi; 2011 [cited 2019 Feb 05]. Available from:
5. Gupta Sanjay. OTC drug dangers you should know about. [Internet]. Everydayhealth; 2014 Mar 20 [cited 2019 Feb 06]. Available from:
http://www.everydayhealth.com/news/over-the-counter-drug-dangers-should-know-about/ accessed on 4 Jan, 2017.
6. Mercola J. Unexpected dangers of over the counter medicines. [Internet]. Mercola; 2019 [cited 2019 Feb 08]. Available from:
7. Adverse effects [Internet]. Wikipedia; 2019 [cited 2019 Feb 12]. Available from:
8. Food and Drug administration; [Internet]. Wikipedia; 2019 [cited 2019 Feb 11]. Available from:
9. Health ministry bans 344 drugs, including Nimesulide. Express news service [Internet]. Indianexpress; 2016 Mar [cited 2019 Feb 10]. Available from:
10. Khan Md. Y. A review on Marketing of OTC Drugs, Pharmacy infopedia. Saroj institute of technology and management, Lucknow [Internet]. Pharmatutor; 2016 Nov 10 [cited 2019 Feb 12]. Available from:
11. Proposed listing changes for OTC items [Internet]. 2016 Jan [cited 2019 Feb 10]. Available from:
12. Gulrajani R. OTC in India [Internet]. 2011 Feb 15 [cited 2019 Feb 09]. Available from:
http://www.slideshare.net/rahulgulrajani/otc-in-india?qid= 7a474011-5a4e-4b2e-8bb5-b0db1d602449&v=&b= &from_search=3
13. Zahid. Complete list of 344 drugs banned by the Ministry of the Health family welfare [Internet]. National health portal: India; 2016 Mar 15 [cited 2019 Feb 05]. Available from: National health portal India. 15 March, 2016; available from:
14. OTC medicines: know your risks and reduce them. [Internet]. familydoctor.org; 2017 Jan 02 [cited 2019 Feb 09]. Available from:
https://familydoctor.org/otc-medicines-know-your-risks-and-reduce-them/ accessed on 2 Jan, 2017.
15. 2013 over the counter benefit catalog; By Care 1st health plan. [Internet]. 2013 [cited 2019 Feb 05]. Available from:
https://www.care1st.com/media/pdf/medicare/Care1st_OTC_2013_Catalog.pdf accessed on 29 March, 2017.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM